Auro Laboratories Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Auro Laboratories Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
29.98% Fall from 52W High
27.3
TTM PE Ratio
Below industry Median
17.3
Price to Book Ratio
Below industry Median
3.2
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is less than 1
0.1
RSI
RSI is mid-range
49.1
MFI
MFI is mid-range
39.4

Auro Laboratories Ltd shareholding Pattern

Promoter
52.2%
Public
47.8%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%

Auro Laboratories Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
7
Bearish Moving Averages
9
5Day EMA
230.10
10Day EMA
232.40
12Day EMA
232.80
20Day EMA
230.50
26Day EMA
226.60
50Day EMA
209.40
100Day EMA
183.60
200Day EMA
154.30
5Day SMA
232.10
10Day SMA
228.60
20Day SMA
243.00
30Day SMA
226.80
50Day SMA
202.00
100Day SMA
173.60
150Day SMA
156.30
200Day SMA
144.20
Delivery & Volume
Resistance & Support
227.43
Pivot
Resistance
First Resistance
231.47
Second Resistance
239.03
Third Resistance
243.07
Support
First Support
219.87
Second support
215.83
Third Support
208.27
Relative Strength Index
49.08
Money Flow Index
39.44
MACD
6.20
MACD Signal
10.62
Average True Range
14.66
Average Directional Index
27.13
Rate of Change (21)
11.70
Rate of Change (125)
52.31
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Bal Pharma Ltd.
160.34
80.6
132.2
Ind-Swift Ltd.
124.69
8.63
31.09
Parnax Lab Ltd.
-
-
-
Aarey Drugs & Pharmaceuticals Ltd.
127.84
28.2
68
Krebs Biochemicals & Industries Ltd.
142.82
59.3
93.2
Auro Laboratories Ltd.
-
-
-
Sotac Pharmaceuticals Ltd
-
-
-

Auro Laboratories Ltd Company background

Founded in: 1989
Managing director: Sharat Deorah
Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the firstline treatment for type 2 diabetes. The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra. The facility has all the required certifications from Indian authorities and European registration organizationSince inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards. Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA.The Companys primary focus was on AntiDiabetic Drugs, which estimated to be one of the fastest growing therapeutic segments. Currently, it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally, it also undertake Toll/Custom Manufacturing for APIs and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum.Auro laboratories has made its presence felt in international markets with a bulk of it production being exported to South East Asia, Middle East and several European Countries. Some of the countries the company exports to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom.The Company received ISO 9001:2000 and WHO cGMPs certification. It also received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006.
Read More

Auro Laboratories Ltd FAQs

The Mutual Fund Shareholding was 0.01% at the end of .

You can easily buy Auro Laboratories Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage